Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
39,791,657
-
Share change
-
+890,054
-
Total reported value
-
$17,882,191,790
-
Put/Call ratio
-
165%
-
Price per share
-
$449.75
-
Number of holders
-
517
-
Value change
-
+$419,688,787
-
Number of buys
-
264
-
Number of sells
-
239
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q3 2018
As of 30 Sep 2018,
ABIOMED INC - COMMON STOCK (ABMD) was held by
517 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,791,657 shares.
The largest 10 holders included
Vanguard Group Inc, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, BROWN CAPITAL MANAGEMENT LLC, AQR CAPITAL MANAGEMENT LLC, BAILLIE GIFFORD & CO, FRANKLIN RESOURCES INC, and Palo Alto Investors LP.
This page lists
518
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.